Chronic stress drives ovarian cancer progression via myeloid-derived suppressor cells infiltration and Notch signaling pathway activation.
Saved in:
| Title: | Chronic stress drives ovarian cancer progression via myeloid-derived suppressor cells infiltration and Notch signaling pathway activation. |
|---|---|
| Authors: | Rivera-López YA; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Torres-Rosado AP; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Casiano-Martínez JA; Department of Biomedical Sciences, School of Dental Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Meléndez-Rodríguez LL; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Imad-Hamad R; Department of Biology, University of Puerto Rico, Mayagüez, Puerto Rico., Hernández-Carrasquillo SM; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Rivera-Pérez LM; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Ortiz-León M; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Torres-Rodríguez OI; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Aquino-Acevedo AN; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Castillo-Ocampo Y; Department of Allied Health, University of Puerto Rico, Ponce, Puerto Rico., Duffey G; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States., Pérez-Morales J; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States., Townsend MK; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States., Peres LC; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Rodriguez PC; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Tworoger SS; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States., Armaiz-Pena GN; Department of Basic Sciences, Division of Pharmacology, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico.; Department of Biomedical Sciences, School of Dental Medicine, Ponce Health Sciences University, Ponce, Puerto Rico.; Divisions of Cancer Biology, Mental Health, and Women's Health, Ponce Research Institute, Ponce, Puerto Rico. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 19; Vol. 16, pp. 1593299. Date of Electronic Publication: 2025 Dec 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1593299 |
